Status:
COMPLETED
Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients with Chronic Migraine and Medication Overuse
Lead Sponsor:
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Conditions:
Migraine Headache
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Chronic Migraine is a disabling condition that affects the 2% of migraine population. It is often associated with medication overuse that makes this condition very difficult to treat. The literature o...
Detailed Description
Background and significance Chronic Migraine is a disabling condition that affects the 2% of migraine population. It is often associated with medication overuse that makes this condition very difficul...
Eligibility Criteria
Inclusion
- Years age \>18 yrs
- clinical diagnosis of Chronic Migraine with medication Overuse
- withdrawal treatment at the Besta institute
- written informed consent
Exclusion
- none
Key Trial Info
Start Date :
December 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2021
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04389372
Start Date
December 15 2021
End Date
December 15 2021
Last Update
January 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UOC Neurologia 3
Milan, Milano, Italy, 20133